{
  "abstract": "SARS-CoV-2 evolution toward antigenically distinct lineages drives escape from host immunity. JN.1 lineage derivatives have recently dominated the global epidemiologic landscape. In preclinical models, an LP.8.1-adapted BNT162b2 vaccine elicited higher serum neutralizing antibody responses against contemporary, circulating JN.1 sublineages, including the epidemiologically dominant XFG lineage, as compared to JN.1 and KP.2 vaccines. These findings supported the selection of an LP.8.1-adapted vaccine for the composition of the 2025-26 COVID-19 vaccine formula.",
  "abstract_shown": true,
  "affiliations": [
    "Pfizer Vaccines, Pearl River, New York, NY USA",
    "Pfizer Data Sciences and Analytics, Pearl River, New York, NY USA",
    "BioNTech, Mainz, Germany"
  ],
  "article_type": "brief report",
  "arxiv": null,
  "author_total": 25,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Chaitanya Kurhade"
    },
    {
      "affs": [
        0
      ],
      "name": "Wei Chen"
    },
    {
      "affs": [
        0
      ],
      "name": "Weiqiang Li"
    },
    {
      "affs": [
        0
      ],
      "name": "Kristin R. Tompkins"
    },
    {
      "affs": [
        0
      ],
      "name": "Lyndsey T. Martinez"
    },
    {
      "affs": [
        0
      ],
      "name": "Swati Rajput"
    },
    {
      "affs": [
        0
      ],
      "name": "Emily Babiarz"
    },
    {
      "affs": [
        0
      ],
      "name": "Aaron Yam"
    },
    {
      "affs": [
        0
      ],
      "name": "Shin-Ae Lee"
    },
    {
      "affs": [
        0
      ],
      "name": "Shikha Shrivastava"
    },
    {
      "affs": [
        0
      ],
      "name": "Sarah O’Leary"
    },
    {
      "affs": [
        0
      ],
      "name": "Subrata Saha"
    },
    {
      "affs": [
        0
      ],
      "name": "Hui Yao"
    },
    {
      "affs": [
        0
      ],
      "name": "Li Hao"
    },
    {
      "affs": [
        1
      ],
      "name": "Todd Coffey"
    },
    {
      "affs": [
        2
      ],
      "name": "Carla Iris Cadima Couto"
    },
    {
      "affs": [
        2
      ],
      "name": "Alexander Muik"
    },
    {
      "affs": [
        0
      ],
      "name": "Raquel Munoz Moreno"
    },
    {
      "affs": [
        0
      ],
      "name": "Wesley Swanson"
    },
    {
      "affs": [
        0
      ],
      "name": "Pilar Mendoza"
    },
    {
      "affs": [
        2
      ],
      "name": "Uğur Şahin"
    },
    {
      "affs": [
        0
      ],
      "name": "Annaliesa S. Anderson"
    },
    {
      "affs": [
        0
      ],
      "name": "Kena A. Swanson"
    },
    {
      "affs": [
        0
      ],
      "name": "Pirada Suphaphiphat Allen"
    },
    {
      "affs": [
        0
      ],
      "name": "Kayvon Modjarrad"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/cm4myxykqbscr.bib",
  "cited_by": 1,
  "doi": "10.1038/s41541-026-01515-8",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13714261/",
  "id": "cm4myxykqbscr",
  "issns": [
    "2059-0105"
  ],
  "landing_url": "https://doi.org/10.1038/s41541-026-01515-8",
  "language": "en",
  "licence": "CC-BY-NC-ND-4.0",
  "licence_label": "CC BY-NC-ND 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-nd/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Brief Communication"
    ],
    [
      "openalex",
      "2725|SARS-CoV-2 and COVID-19 Research"
    ]
  ],
  "openalex": "W4417414733",
  "pdf_url": "https://www.nature.com/articles/s41541-026-01515-8_reference.pdf",
  "pmcid": "PMC13714261",
  "pmid": "42409841",
  "published": "2026-07-06",
  "publisher": "Nature Publishing Group",
  "ris": "https://research.draconitic.com/paper/cm4myxykqbscr.ris",
  "sources": [
    {
      "first_seen": "2026-11-01T12:21:47Z",
      "native_id": "PMC13714261",
      "source": "pmc",
      "url": "https://doi.org/10.1038/s41541-026-01515-8"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2725|SARS-CoV-2 and COVID-19 Research",
      "subfield": "infectious-disease"
    }
  ],
  "title": "Preclinical immunogenicity of the LP.8.1-adapted BNT162b2 COVID-19 vaccine",
  "title_text": "Preclinical immunogenicity of the LP.8.1-adapted BNT162b2 COVID-19 vaccine",
  "type": "peer-reviewed",
  "updated_at": "2026-11-01T12:21:47Z",
  "url": "https://research.draconitic.com/paper/cm4myxykqbscr",
  "venue": "NPJ Vaccines",
  "versions": []
}